SCHEMBL13073639

SCHEMBL13073639

O=C1C=CC(=O)N1C(=O)c1ccc(C(OCCN2CCN(CCO)CC2)(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SLC6A1 P30531 4/20 0.46
SLC6A11 P48066 4/20 0.42
KCNA5 P22460 5/20 0.40
GAA P10253 1/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
ALDH1A1 P00352 2/20 0.39
DRD3 P35462 2/20 0.39
DRD2 P14416 1/20 0.39
LMNA P02545 1/20 0.38
HTT P42858 1/20 0.38
TP53 P04637 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
SLC6A12 P48065 1/20 0.38
SLC6A13 Q9NSD5 1/20 0.38
NAMPT P43490 1/20 0.38
POLB P06746 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13073178 0.86 KIF11 (0.40) SLC6A1SLC6A11GAA
SCHEMBL13073176 0.82 DUT (0.42) SLC6A1SLC6A11GAANAMPT
SCHEMBL13073640 0.79 SLC6A1 (0.44) SLC6A1SLC6A11GAAMEN1KMT2A
SCHEMBL13073487 0.78 SLC6A1 (0.43) SLC6A1SLC6A11GAAMEN1KMT2A
SCHEMBL13073477 0.77 GAA (0.39) KCNA5GAAMEN1KMT2AALDH1A1
SCHEMBL13073128 0.77 SLC6A1 (0.44) SLC6A1SLC6A11MEN1KMT2AALDH1A1
SCHEMBL13073177 0.76 TK2 (0.42) SLC6A1SLC6A11
SCHEMBL13073642 0.74 P2RX7 (0.39) SLC6A1MEN1KMT2AALDH1A1LMNA
SCHEMBL13073622 0.74 P2RX4 (0.38) MEN1KMT2AALDH1A1
SCHEMBL13039332 0.73 CES1 (0.41) MEN1KMT2ALMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9034798-B2 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions CAPROTEC BIOANALYTICS GMBH (DE) 2015-05-19 US disclosed
US-20100298168-A1 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions HK PHARMACEUTICALS, INC. 2010-11-25 US disclosed
US-20100248264-A1 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions HK PHARMACEUTICALS, INC. 2010-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100298168-A1 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions CHLSN, PTMS, SRMS SLC6A1 4805/4885SLC6A11 4794/4885KCNA5 4684/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.